Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Samantha Nicolau, PhD
Sanofi
Poster(s):
(P-1216)
Comparison of the
in vivo
Efficacy and Resistance Development Potential between Cefiderocol (FDC) and Ceftolozane/tazobactam (C/T) Human Simulated Exposures against
Pseudomonas aeruginosa i
n 72 Hour Murine Thigh Infection Model
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1341) Differential Frequency of Persister cells in Clinically Derived
Pseudomonas aeruginosa
Isolates after Exposure to Cefiderocol (FDC) or Ceftolozane/tazobactam (C/T)
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT